Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Edwards Lifesciences Corporation

Edwards Lifesciences Announces CFO Transition Plan
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports First Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Reports Third Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Edwards Lifesciences Completes Sale of Critical Care
From Edwards Lifesciences Corporation
Via Business Wire
Tickers EW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.